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ABSTRACT 	  
 Rothia mucilaginosa (Rm) is a gram-positive bacterium residing in the oral 
cavity. Recent studies in our laboratory have shown that this microorganism is able to 
cleave gluten, including immunogenic domains implicated in celiac disease.  This can be 
beneficial to patients with celiac disease because exploitation of Rm can provide a novel 
mode of treatment.  The enzymes responsible for this cleavage are as yet unknown.  The 
purpose of this study was to optimize the transformation efficiencies of Rm cells through 
electroporation, with the ultimate goal to create knock-out mutants for enzyme activity.   
We have determined various aspects of Rm cells relevant for this project: (1) the growth 
curve characteristics of Rm; (2) the presence of endogenous restriction enzyme activities; 
and (3) the conditions facilitating Rm electroporation by varying electroporation 
voltages.  Furthermore, electroporation and transformation of the plasmid pUC18 was 
conducted in Escherichia coli.  The growth curve of Rm cells in BHI growth medium 
incubated at 37°C while shaking showed a doubling time of approximately 3 hours in the 
logarithmic growth phase. Using a cell sonicate of Rm cells incubated with Lambda DNA 
and four different restriction enzyme buffers, we found that there were no apparent 
endogenous restriction enzyme activities detectable. For the electroporation experiments, 
we used previously published protocols for the bacterium Staphylococcus aureus, as a 
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standard condition to electroporate Rm cells.  Those studies have shown that changing 
electrical parameters during the electroporation would yield a high efficiency rate of 
gram-positive bacterial transformation (Lofblom et al., 2006; Metzler et al., 1992).  
Therefore in our study, we increased the field strengths (kV*cm-1) to electroporate Rm 
cells.  Rm cells could not be successfully transformed, and we observed that field 
strengths exceeding 18 kV*cm-1 destroyed Rm cells. On the other hand, the 
transformation of E. coli with pUC18 was successful. Our studies have laid the 
groundwork for investigating the transformation of Rm cells, and future studies can use 
the results obtained to further investigate ways to optimize transformation of Rm cells for 
potential utility in celiac patients. 
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1. Introduction 
1.1 Celiac’s Disease overview 
Celiac disease (CD), one of the most common autoimmune diseases, is prevalent 
in about 1% of the western population (Green et al. 2007).  Both genetic and 
environmental factors determine the development of CD.  The disorder is caused by 
intolerance of gluten that is primarily present in wheat, rye, and barley.  Ingestion of 
specific protein components in these cereals: gluten, gliadin and glutenin damage the 
mucosa of the small intestines that ultimately leads to nutrient malabsorption (Thompson 
1997).  Subsequently, malabsorption of nutrients can bring about many different clinical 
complications associated with celiac disease, including abdominal pain, diarrhea, iron 
deficiency anemia, osteoporosis, and weight loss (Green et al. 2007). 
Difficulties digesting gluten 
In addition to this environmental factor of consuming gluten, patients are also 
genetically predisposed to CD.  The majority of CD patients express Human Leukocyte 
Antigen (HLA)-DQ2 and/or DQ8 (Spurkland 1997).  However it is important to note that 
not all individuals with HLA-DQ2 and/or DQ8 develop CD, illustrating that the 
genotypes are necessary but not sufficient for the development of CD.  As 
aforementioned, gluten consists of gliadins (alcohol-soluble) and glutenins (alcohol-
insoluble), which are characterized by high levels of glutamine (30-35%) and proline (10-
15%) residues that play a key role in the pathogenesis of CD.  The intestinal 
inflammation that is common among CD patients have been linked with increase mucosal 
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activity of tissue transglutaminase (TGase) (Molberg 1998).  TGase deamidation of 
gliadins creates an epitope that binds directly to DQ2 and activates the gut-derived T-
cells, causing an immune response (Molberg 1998).  In addition, high levels of proline in 
gluten allow it to escape the digestion by gastrointestinal enzymes (Shan et al. 2002). 
Gluten-free diet  
Currently, the main method to treat the disease is by adhering to strict gluten-free 
diet in order to avoid deleterious downstream effects.  However, because of the unique 
visco-elastic properties of gluten, it is widely used in the food industry especially in 
giving bread its texture and taste.  Gluten proteins are not only present in bread and 
cookies, but are also found in sauces, instant soups and even in medications (Tjon 2010). 
Therefore, compliance to the gluten-free diet is unequivocally difficult for CD patients, 
especially for those living in Western Europe and United States where daily intake of 
gluten is high.  In addition, there are subset of CD patients who are not responsive to the 
gluten-free diet and continue to have gluten-induced health problems (Dewar 2012).  
Patients who do not respond to gluten-free diets need immunosuppressive therapy.  
Other approaches to treat CD patients 
Different approaches to treat CD have been suggested, such as genetic 
modification of wheat, enzyme therapy and gluten binders (Schuppan et al. 2009).  
Gluten-degrading enzymes from various bacteria and fungi have been exploited for the 
use of developing a novel therapeutic method.  For instance, prolyl endopeptidases (PEP) 
can cleave gluten peptides into small nontoxic peptides before they reach the intestinal 
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epithelium (Shan et al. 2002).  PEP is expressed in various microorganisms such as 
Flavobacterium meningosepticum, Sphingomonas capsulata, Aspergillus niger and 
Myxococcus xanthus (Mitea 2008 and Shan 2004).  Another enzyme is the glutamine 
endoprotease from barley called EP-B2 (Bethune et al., 2006).  EP-B2 cleaves after 
glutamine residues, usually with proline, and provides another method of therapy (Davy 
et al., 1998).  However, these microorganisms are not naturally associated with the 
human microbiome and F. meningosepticum and A. niger can induce toxic effects.  Our 
lab has identified Rothia bacteria, which are natural colonizers of the oral cavity, as one 
of the microorganisms that produce gluten-degrading enzymes (Zamakchchari et al. 
2011).   
1.2 Rothia mucilaginosa: cellular characteristics 
R. mucilaginosa is a gram-positive bacterium that primarily colonizes the oral 
cavity and other parts of the body, including upper respiratory tract and the duodenum 
(Collins et al., 2000, Ou et al., 2009).  R. mucilaginosa was previously known as 
Stomatococcus mucilaginosus and is generally considered a harmless colonizer.  
Nevertheless, R. mucilaginosa has occasionally been implicated with infections such as 
endocarditis (Pinsky et al., 1989, Rubin et al., 1978, Prag et al., 1985), pneumonia (Cho 
et al., 2013), periodontitis (Hodzic and Snyder 2010), and other infections that are 
associated with organ or tissue transplantation (Lee et al., 2008, Chavan et al., 2013).   
R. mucilaginosa is a facultative anaerobic bacterium, capable of living in an 
aerobic environment (Pasciak et al. 2004).  This microorganism consists of encapsulated, 
non-spore-forming, and nonmotile spheres (Bergan 1982) and colonies look smooth, 
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convex, white or transparent (Pasciak et al. 2004).  What distinguishes R. mucilaginosa 
from other gram-positive cocci such as streptococci or enterococci is the inability to grow 
when the nutrient agar is supplemented with 5% NaCl (Ruoff, 2002).  Our laboratory is 
interested to genetically modify Rm cells to identify the enzymes that are encoded in the 
genome of this microorganism.  
 
1.3 Bacterial DNA exchange 
Most bacteria contain a single circular DNA and can transfer or exchange DNA 
with one another in three different ways: transformation, conjugation and transduction.  
All three mechanisms are considered to be horizontal gene transfer.  It is crucial to 
understand the importance of plasmids in bacteria.  Plasmids are small, circular extra-
chromosomal DNA that can carry genes that are essential for the cells’ survival.  For 
instance, bacteria can carry genes for antibiotic resistance, making them potentially 
dangerous pathogens.  In addition, bacteria can also have plasmids that contain virulence 
genes enabling them to cause disease in the host.  Usually, plasmids are able to replicate 
autonomously from the genomic chromosome.  Cells may contain no plasmids, one 
plasmid or many copies of a plasmid.  At the same time, a single host can carry a number 
of different plasmids as well.  There are three known mechanisms for bacterial exchange 
of DNA: transformation, conjugation and transduction.  These will each be discussed in 
detail. 
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Transformation 
Transformation is the process by which bacteria are able to pick up DNA 
from their environment, usually DNA remnants from other dead bacterial cells.  
In order to take up exogenous DNA and undergo genetic transformation, the 
bacteria need to be in a favorable physiological state, or competent.  The process 
of natural bacterial transformation is very complex and requires numerous genes 
that encode for proteins that are involved in the transport of DNA into the cell 
(Chen and Dubnau 2004). 
Conjugation 
Conjugation is often regarded as a form of sexual reproduction or mating 
because it is characterized as a transfer of genetic material through a direct 
contact between donor and recipient.  This mechanism requires a special type of 
plasmid called the F plasmid or sex plasmid.   
Bacteria that have an F plasmid are known as F+ or male and likely, those 
without an F plasmid are called F- or female.  The sex plasmid genes are 
responsible for the synthesis of special pili called sex pili.  These sex pili, long 
and hollow protein tubes, have receptors that are able to bind to ligands on the 
recipient cell walls.  Through this conjugation bridge, DNA passes between the 
donor and recipient cells, allowing for DNA exchange or transfer. 
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Transduction 
Transduction is another method of genetic transfer from one bacterium to 
another.  However, this method involves a bacteriophage that is able to introduce 
foreign DNA.  A phage is a type of virus that infects bacteria and therefore is an 
obligatory intracellular parasite that is only able to reproduce when invading a 
host cell.  For instance, the phage T4 is capable of infecting E. coli and the phage 
T4 DNA continues to multiply eventually taking over the entire metabolism of E. 
coli.  Then, those genes direct the synthesis of different components of T4 until 
the E. coli cell is lysed, releasing the newly constructed phages.  The phage that 
carries the bacterial DNA can now infect another cell. 
1.4 Bacterial transformation in the lab 
The natural function of bacterial transformation is often exploited for genetic 
engineering in laboratories.  Plasmids, as mentioned before, contain important genetic 
information that is essential for cell’s survival.  For instance, antibiotic genes in plasmids 
are passed among themselves.  This characteristic of plasmids is manipulated in order to 
be able to study the gene of interest.  The antibiotic resistance gene is often used as 
marker genes to isolate the bacteria that have gone through successful transformation.  
However, in order for bacteria to undergo transformation, they must be competent.   The 
competency of the bacterial cells help determine how efficient plasmids can enter the 
bacteria.  In molecular biology, many scientists artificially create cell competency (see 
Section 1.8).   
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To knock-out genes 
A “gene knockout” is a technique used to inactivate the gene in a cell or an 
organism by replacing it or disrupting it with an artificial piece of DNA..  Knocking 
out the activity of genes gives important information regarding the cellular function 
of that gene.  Knockouts are compared to wild-type organisms in order to fully 
understand the role of the specific gene that is inactivated.  Gene targeting 
technique is widely used as a way to modify genes at the genomic level by adding 
or deleting the gene of interest.  This is achieved through the use of homologous 
recombination.  Homologous recombination between foreign DNA and existing 
homologous sequences in the mammalian genome has been used since the 
beginning of eighties to manipulate endogenous genes (Smithies et al. 1985).   
To add genes 
Introducing a foreign gene into a bacterium is very simple and similar to 
knocking out genes.  However, expressing a gene to produce proteins become 
difficult if the source of the gene is from eukaryotic genes such as fungi, plants or 
animals. This is primarily due to major differences between prokaryotic cells and 
eukaryotic cells of protein synthesis. Unlike DNA of prokaryotic cells, eukaryotic 
DNA contains exons, coding sequences, and introns, intervening sequences.  In 
eukaryotic cells, DNA is used as a template to create mRNA, which then undergo 
mRNA splicing to remove introns and allow exons to join forming a mature 
mRNA.  Therefore, introducing a eukaryotic gene to bacteria requires a different 
approach.  Most importantly, DNA needs to be created using the already spliced 
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mature mRNA by using reverse transcriptase.  This enzyme uses the mature mRNA 
to create a double-stranded DNA molecule called cDNA, which is then 
incorporated into the plasmid being cloned to express a gene to produce a protein.  
Another problem with expressing human genes in bacterial expression systems is 
that the codon usage between bacteria and mammalian cells differ.  Mammalian 
genes frequently use codons that are not commonly used in bacteria, which can 
cause problems if one is trying to express a mammalian gene in bacteria.  To make 
things more complex, there is also evidence of codon usage bias even among 
bacteria themselves (Sharp and Bailes et al., 2005).  Lastly, bacteria will not carry 
out any post-translational modifications (phosphorylation, glycosylation) of 
proteins.  
1.5 Rendering cells competent 
As mentioned before, competency of bacterial cells is critical for the efficiency of 
transformation. Genetic manipulation of bacteria requires the ability to take up exogenous 
DNA from the environment or from another bacterium. Therefore, the permeability of 
cells becomes increasingly important during bacterial transformation. There are several 
ways to make bacterial cells more permeable to plasmids in order to readily take up 
foreign DNA. One method is by the use of chemicals to make bacteria cell walls 
penetrable, while other methods exploit the use of temperature and electric pulses. 
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Chemical method and principle 
There are several chemical methods established to induce a transient breakdown 
of the cell membrane.  Mendel and Higa (1970) first demonstrated bacterial 
transformation by incubating E. coli cells and bacteriophage DNA with a solution 
of CaCl2.  Exposing bacteria to a calcium-rich environment disrupts the cell 
membranes to accept plasmids.  The exact mechanism of cell permeability 
increase following CaCl2 treatment is still a topic of debate.  However, the initial 
step of the DNA adsorption on the cell surface has been suggested to be due to the 
positively charged calcium ions. The calcium ions neutralize the negative charge 
of both the plasmid and bacterial cell wall, which decreases the electrostatic 
repulsion and weakens the cell wall (Panja 2008).  The chemical methods of 
transformation require many steps such as centrifugation, washing, long-term 
incubation and usually heat-shock.  However, a simple one-step procedure was 
established by the use of Transformation & Storage Solution (TSS) containing 
pUC19 DNA (Chung et al. 1989).   
Heat-shock and principle 
A brief heat shock step depolarizes the inner membrane and decreases the 
potential barrier for the movement of the negatively charged DNA to enter the 
cell interior (Panja, 2006).  After the sudden increase in temperature, returning the 
cells to a lower temperature allows the cell wall to self-heal.  Using the heat-
shock method in conjunction with chemically competent approaches dramatically 
increase the efficiency of transformation (Panja, 2006).   Therefore, chemically 
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competent cells are used with heat-shock in order to increase the permeability of 
exogenous DNA for transformation.  It is important to note that these studies are 
applicable to gram-negative cells such as E. coli, but have not been used for gram-
positive cells.  
Electroporation and principle 
Electroporation is another method used to introduce macromolecules in the cells 
both in prokaryotes and eukaryotes (Shigekawa, 1988).  Therefore, electroporation is 
frequently used during transformation of bacteria as a way to increase the permeability of 
the cell membrane to uptake foreign DNA.  This technique applies an external electric 
field of short high-voltage pulses to induce a temporary and reversible breakdown of the 
cell membrane (Knight 1981, 1986).  Wong and Neumann (1982) first demonstrated the 
use of electric fields for the introduction of DNA into a cell.  They described that the high 
intensity of electric impulse increased the uptake of DNA into mouse lyoma cells 
(Neumann et al. 1982).  Unlike the chemical methods to use high salt concentrations to 
breakdown the cell membrane, the success of electroporation depends primarily on low 
salt content of the plasmid solution.  High salt content of the solution can cause electric 
discharge, which can impact the viability of the bacteria (Ho and Mittal, 1995).  In 
addition, many studies use electroporation for the delivery of therapeutic molecules into 
cells such as drug-based cancer therapy (Rabussay et al. 2002, Gehls 2003, Cemezar 
2006).  
	  	  
  	   11 
1.6 Electroporation of gram-positive bacteria 
Electroporation of gram-positive bacteria is known to be more difficult than gram-
negative bacteria, possibly due to structural differences.  Gram-positive bacteria have a 
thick peptidoglycan layer on the outside of the cell membrane whereas gram-negative 
bacteria have either a thin layer between cell membranes. The thick peptidoglycan layer 
could be a potential barrier to DNA uptake (Rattanachaikunsopon, 2009).  Therefore, 
various parameters need to be modified for a successful transformation of gram-positive 
bacteria and these parameters may differ depending on the strain.  The parameters include 
1) composition of electroporation solution; 2) cell growth condition; 3) electric field 
strength; 4) size, concentration and purity of DNA used for transformation; 5) conditions 
used to select for transformants (Dunny et al., 1991).  There are many studies with 
optimized protocols to improve transformation efficiency of gram-positive bacteria.  For 
instance, adding substances in the growth media that inhibit the synthesis of the 
peptidoglycan cell wall of gram-positive bacteria are beneficial (Eynard and Teissie, 
2000).  Reagents such as glycine are used to make Staphylococcus aureus, Streptococcus 
pyogenes and Streptrococcus suis more permeable to the incoming DNA by directly 
affecting the rigidity of the cell wall (Pajunen et al., 2005).  
1.7 Aim of the study 
Our lab has found that gluten-degrading microorganisms naturally colonize the oral 
cavity (Helmerhorst 2010).  The bacteria, degrading gluten, were identified as Rothia 
bacteria (Zamakhchari 2011).  Gluten-degrading enzymes are being explored as novel 
treatment avenue for CD (Bethune and Khosia 2012).  Specifically, we would like to 
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identify the specific gluten-degrading enzyme in the Rothia bacteria.  In this study, we 
will attempt to optimize conditions to transform Rothia mucilaginosa cells by 
electroporation, with the ultimate goal to create a genetic knock out library of this 
microorganism.  In order to successfully electroporate and transform R. mucilaginosa 
cells, various parameters need to be examined: 1) the growth curve of R. mucilaginosa 
cells; 2) the presence of endogenous restriction enzymes in the cytoplasm; 3) the 
efficiency of the sonication settings for electroporation of R. mucilaginosa cells. 
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2. Materials and Methods 
2.1 Solutions and Reagents 
1. Brain-Heart Infusion broth (BHI): 37 g of Brain-Heart Infusion (Becton, 
Dickinson, Sparks, MD; ref number 211059) immersed in 1 L of distilled H2O. 
Autoclave. 
2. 10mM Tris, 1mM EDTA (pH=8): 0.6 g of Tris (Fisher Scientific, NJ) in 500 mL 
of H2O and 0.146 g of EDTA (Sigma-Aldrich, MO) in 500 mL of H2O were 
combined to make 1 L of 10 mM Tris,1 mM EDTA and calibrated to final pH of 8 
using a pH meter (Model SA720 Orion).   
3. 1X Restriction Enzyme Buffers: 100uL of 10X buffer 1.1, 2.1, 3.1, and 4.1 (New 
England BioLabs NEBuffer B7200S) and 900 µL of H2O. 
4. 50 ng/µL of Lambda DNA in 1X buffer: 10µL of Lambda DNA (500 µg/mL) was 
diluted to 50 ng/µL in 1X buffers. 
5. SMMP: 55 ml 2X SMM, 40 ml 4X Penassay broth, 5 ml 10% (w/v) bovine 
albumin; adjust pH to 7.0; filter sterilize 
6. Trypticase soy agar: 40 g trypticase soy agar (Becton Dickinson, Sparks, MD) in 
1 L of water. Autoclave 
7. 2X SMM: 25 ml 0.2 M sodium hydrogen maleate, 40 ml 0.1 N NaOH; adjust pH 
to 6.5. Add 5 ml 1M MgCl2, 42.7 g sucrose; dissolve and bring volume to 125 ml. 
Filter sterilize. 
8. 4X Penassay broth: 17.5 g Antibiotic Medium 3 (Becton Dickinson) dissolved in 
250 ml water. Autoclave. 
	  	  
  	   14 
9. 0.2 M sodium hydrogen maleate: 13.7 g maleic acid, 4g NaOH; dissolve in 500 
ml water. Autoclave. 
2.2 Determination of the growth curve of R. mucilaginosa cells 
R. mucilaginosa (Rm) colonies cultured on Brucella agar (Hardy Diagnostics, 
Santa Maria, CA) were inoculated in 50 ml of BHI broth and incubated overnight for 18 
hours at 37°C while shaking at 225 rpm (New Brunswick Scientific). Two ml of the 
culture in BHI was subcultured to 100 ml of pre-warmed BHI and incubated under the 
same condition.  The OD620 of 100 µl of 100:1,000 diluted Rm cells were measured (Cary 
50 Bio UV/Visible Spectrophotometer, Varian Australia) hourly for 24 hours.  
 
2.3 Sonication of Rm cells 
Aliquots of 1.5 ml of Rm cells were centrifuged at 7,500 rpm for 5 minutes. The 
cells were washed in 10 mM TrisHCl buffer (Fisher Scientific, Fair Lawn, New Jersey) 
containing 1 mM EDTA (Sigma-Aldrich, St. Louis, MO), pH 8.  The Rm cells were lysed 
by sonication for 30 seconds, 50% pulsed #2, 3, and 4 settings (Bandson Sonifier 450). 
Sonication steps were repeated 3 times for proper disruption of Rm cells. Measurements 
of OD620 were taken after 3 sonication cycles to confirm lysis of cells with OD620 
reduction by 65%-75%.  The sonicated lysate were pelleted at 13,500 rpm for 2 minutes. 
500 µl of supernatant was transferred to a new Eppendorf tube. 
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2.4 Restriction enzymes assay  
10 µl of Lambda DNA immersed in 50 ng/µl in 1X low salt restriction enzyme 
buffer 1.1, 2.1, 3.1 and 4.1  (New England BioLabs Inc., Ipswich, MA) and 10 µl of 
sonicated lysate were assayed.  The reaction mixture was incubated for 2 hours at 37°C; 
heat inactivated for 5 minutes at 68°C and analyzed by gel electrophoresis for potential 
restriction enzyme activities.  There were two controls for this experiment: the first 
control entailed 10 µL of lysate and 10 µL of buffers, and the second control included 10 
µL of lambda DNA and 10 µL of buffers.   
An agarose gel (1%) was prepared by adding 0.5 g of agarose (Bio-Rad Laboratories, 
Hercules, CA; catalog number 161-3101) to 50 ml of 1X TAE buffer and 10 µl of SYBR 
Green gel stain. 3 µl of ladder and 10 µl of lysate and mixtures were added.  Images of 
the gel were taken to analyze by Versa Doc Imaging System (Bio-Rad, catalog number 
1708010). 
2.5 Preparation of cells for Electroporation 
A colony from a fresh Rm plate was inoculated to 3 ml of BHI broth in 17 x 100 
mm tube and incubated at 37°C overnight, shaking at 250 rpm. 1.5 ml of the overnight 
culture was inoculated into 150 ml of fresh BHI broth in a 1L flask and incubated at 
37°C, shaking at 250 rpm, to ~2 x 108 cells/ml. The cells were cooled in an ice water bath 
for 15 minutes to stop growth and decanted into a sterile 500 ml centrifuge bottle.  The 
cells were harvested by centrifugation at 12,000 x g for 15 minutes at 4°C.  Supernatant 
was carefully pipetted off, while keeping the cell pellet on ice.  The cells were washed 2 
times in 500 ml of sterile, ice-cold water.  The cell pellet was resuspended in 25 ml of 
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sterile, ice-cold 10% glycerol and transferred to a 30 ml sterile Oakridge tube.  The cells 
were pelleted by centrifugation again at 12,000 x g for 15 minutes at 4°C and carefully 
removed the supernatant.  Cell pellet was resuspended in 2 ml of 10% glycerol to the 
final cell concentration of 2.26 x 1012 cells/ml.  Dispensed 250 µL aliquots of the 
electrocompetent cells into sterile 1.5 ml microfuge tubes.  Cells were frozen in an 
isopropanol-dry ice bath, and then stored at -80°C. 
 
2.6 Electroporation transformation of  Rm  
Rm cells (50 µL) were thawed at room temperature for several minutes. Added 4 µL 
(~1µg) of   pUC18 DNA (MiniPrep product, 270ng/ µL) and gently pipetted up and down 
to mix.  Samples were incubated at room temperature for 30 minutes.  The mixture of 
cells and pUC18 were transferred to electroporation cuvettes, and pulsed once with 
Micropulser (BioRad Catalog number: 165-2100) at various conditions as shown in Fig 
5: 1) 1.1 millisecond using 2.1 kV; 2) 2.5 millisecond using 2.1 kV; 3) 4 milliseconds 
using 1.8 kV; 4) 2.5 milliseconds using 1.8 kV.  The cuvette was removed immediately 
and 1 ml of SMMP medium was added containing a sub-inhibitory concentration of 
Antibiotic Medium 3 (Becton Dickinson).  The cells were gently transferred to a sterile 
17 x 100 mm tube using a Pasteur pipette and incubated for 1 hour at 37°C while shaking 
at 250 rpm.  Aliquots of electroporated cells were plated on trypticase soy agar 
containing ampicillin and incubated plates for 36-48 hours at 37°C.  
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2.7 Heat shock transformation of E. coli  
 HT96 NovaBlue Competent Cells (E. coli) were removed from -70°C freezer and 
thawed directly on ice. An aliquot of 1µL (0.2ng) pUC18 plasmid (Thermo Fisher 
Scientific) was added and the suspension was stirred gently with a pipet tip.  Cells were 
directly placed on ice for 5 minutes and then heat shocked by placing the cells in a 
preheated heat block at 42°C for exactly 30 seconds, and incubation on ice for 2 minutes.  
80µL of SOC (provided) was added and then 20µL aliquots of heat shocked E. coli cells 
were plated on LB plates containing 100µg/mL. 
 
2.8 Plasmid Miniprep  
 AxyPrep Plasmid Miniprep Kit was used for Miniprep of E. coli transformants.  4mL of 
an E. coli culture incubated overnight in LB broth was centrifuged at 12,000 x g for 1 
minute to pellet the cells.  The supernatant was decanted and the pellet was resuspended 
in 250µL of Buffer S1 (resuspension buffer).  The cells were vortexed in order to be sure 
that the bacteria are completely resuspended.  250µL of Buffer S2 (lysis buffer) was 
added and mixed gently by inverting the tube for 4-6 times without vortexing.  350µL of 
Buffer S3 (neutralization buffer) was added and mixed gently by inverting 6-8 times.  
The cells were then centrifuged at 12,000 x g for 10 minutes to clarify the lysate.  
Miniprep column was placed into an uncapped 2mL Microfuge tube (provided) and the 
clarified lysate was transferred into the Miniprep column to be centrifuged at 12,000 x g 
for 1 minute.  700µL of Buffer W2 (desalting buffer) was added into the Miniprep 
column and centrifuged at 12,000 x g for 1 minute.  Filtrate was discarded and washed 
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again with 700µL of Buffer W2.  Then the filtrate was discarded from the 2mL 
Microfuge tube and centrifuged at 12,000 x g for 1 minute.  Miniprep column was 
transferred into a clean 1.5mL Microfuge tube (provided) and purified pUC18 plasmid 
was eluted by adding 70µL of Eluent (2.5 mM Tris-HCl, pH 8.5).  The Microfuge tube 
was place in room temperature for 1 minute and centrifuged at 12,000 x g for 1 minute. 
The DNA concentration of the preparation was determined with NonoDrop 
spectrophotometer (NanoDrop 2000c, Thermo Scientific).  We also performed gel 
electrophoresis to confirm the molecular weight of EcoR1-digested pUC18 plasmid to be 
2686 bas pairs (bp) in length.   
 
2.9 Electroporation and transformation of E. coli 
Competent cells (50 µL) were thawed at room temperature for several minutes. To this 
we added 4 µL (~1µg) of   pUC18 DNA (MiniPrep product, 270ng/ µL) and gently 
pipetted up and down to mix.  The mixture of cells and pUC18 were then transferred to a 
0.2 cm electroporation cuvette, and pulsed once with Micropulser (BioRad Catalog 
number: 165-2100) at 2.5 kV without a time constant (standard protocol using 
Micropulser manual).  20 µL of aliquots of electroporated cells were plated on LB 
containing ampicillin and incubated plates for 36-48 hours at 37°C.  
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3. Results 
3.1 Growth curve for Rothia mucilaginosa (Rm) 
 The growth curve characteristics of Rm bacteria were not known, and therefore 
Rm cells were incubated to determine the growth rate.  Colonies of freshly grown Rm 
cells from Brucella agar plate (Figure 1) were inoculated to the liquid media of BHI.   
 
 
 Figure 1. Colony morphology of Rothia mucilaginosa cultured for 48 h on a 
Brucella agar plate at 37°C under aerobic conditions.  
Rm cells grew well in BHI broth. As shown in Figure 2 and Table 1, the bacterial growth 
has a relatively short lag phase ranging from 0 to 2 hours with OD620 from 0.115 to 0.379. 
An exponential logarithmic phase ranged from 3 to 11 hours with OD620 from 0.636 to 
3.72 with the greatest increase in cell density between 5 and 9 hours of incubation (log 
phase).  Finally, a stationary phase was reached with OD620 values ranging from 3.832 to 
4.132.  
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Figure 2. Growth curve of Rothia mucilaginosa (Rm) measured at wavelength of 
620nm.  5 colonies of Rm cells were inoculated to 50 ml BHI and incubated at 37°C with 
shaking at 225 rpm. Then 2 ml of the culture in BHI was subcultured to 100 ml of pre-
warmed BHI and the OD620 measurements were collected hourly.  
 
3.2 Lysis of Rm cells by sonication 
 To examine whether Rm cells lysed successfully after sonication, OD620 
measurements were made after each cycle.  Before sonication, Rm cells at late 
logarithmic stages were suspended in 4 different restriction enzyme buffers (buffers 1.1, 
2.1, 3.1, and 4.1).  The data demonstrated that the OD620 before sonication were 4.01, 
3.91, 3.82, and 4.19, respectively (Figure 3), and decreased to 1.42, 1.42, 1.28 and 1.04 
after 3 cycles of sonication.  Results indicated that 65%-75% of cells lysed after 3 
sonication cycles (Figure 3).  
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Table 1. Table of OD620 measurements during 24 hours of Rm incubation.  
Time (hour) OD 620 
0 0.115 
2 0.379 
3 0.636 
4 0.981 
5 1.668 
6 2.277 
7 2.819 
8 3.178 
9 3.386 
10 3.585 
11 3.728 
12 3.832 
13 3.908 
14 3.872 
15 3.946 
16 4.067 
19 4.053 
24 4.132 
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Figure 3. Effect of sonication on Optical density of Rm cells after 3 subsequent 
cycles.  The Rm cells were lysed by sonication for 30 seconds, 50% pulsed in the order of 
#2, 3, and 4 settings.  Measurements of OD620 were taken after 3 sonication cycles to 
confirm lysis of cells with OD620 reduction by 65%-75%. 
 
Table 2. Percent change of Rm cell lysis after 3 cycles of sonication 
Buffers Initial Final % Change 
1.1 4.01 1.42 64.6 
2.1 3.91 1.42 63.7 
3.1 3.82 1.28 66.5 
4.1 4.19 1.04 75.2 
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  2	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  3	  1.1	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   2.25	   1.42	  2.1	  Buffer	   3.91	   2.53	   1.72	   1.42	  3.1	  Buffer	   3.82	   2.58	   1.96	   1.28	  4.1	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   4.19	   2.52	   1.45	   1.04	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3.3 Presence of Restriction Enzyme Activities 
 To determine for the presence of restriction enzyme activities in Rm bacteria, Rm 
lysate in NEB buffers 1.1, 2.1, 3.1, or 4.1 were incubated with lambda DNA. The 
rationale for using these four buffers was to investigate the different activity levels of 
enzymes in various buffers because not all enzymes are active in one buffer.   
 In all buffers, there was no evidence of restriction enzyme activities, as indicated 
in Figure 4.  The mixture of buffer 1.1 (lysate + lambda DNA) in Lane 3 showed two 
bands that were similar to the lysate control in L1 and the lambda DNA control in Lane 2.  
This indicated that in buffer 1.1, there were no restriction enzyme activities that cut the 
lambda DNA. In buffers 2.1 and 4.1, the mixtures showed three bands.  Specifically for 
buffer 2.1 mixtures in Lane 5, the three bands are clearly present.  Two of the bands were 
from the lysate control (L2) and the other band originated from lambda DNA control 
(Lane 4). Interestingly, mixture 3.1 in well 7 showed one band that was indicative of 
lambda DNA shown in Lane 6.  The lysate control 3.1 (L3) did not have any bands and 
similarly, mixture 3.1 (Lane 7) showed no bands.  Therefore, it can be concluded that 
there were no restriction enzyme activities present in Rm cells that could interfere with 
downstream transformation efforts.  
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Figure 4. Gel electrophoresis of Rm cell lysate and lambda DNA. 10 µl of Lambda 
DNA immersed in1X low salt restriction enzyme buffer 1.1, 2.1, 3.1 and 4.1 and 10 µl of 
sonicated lysate were assayed (Lanes 3, 5, 7, 9, respectively).  First control entailed 10 
µL of lysate and 10 µL of buffers (L1, L2, L3), and the second control included 10 µL of 
lambda DNA and 10 µL of buffers (Lanes 2, 4, 6, 8) 
Table 3. Selected NEBuffer Activity/Performance Table with Restriction Enzymes.   
  
Enzyme 
% Activity in NEBuffer 
1.1 2.1 3.1 CutSmart (4.1) 
HindIII 25 100 50 50 
KasI 50 100 50 100 
NruI 10 10 100 10 
Sau3AI 100 50 10 100 
** www.neb.com for full performance table in NEBuffer 
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3.4 Transformation of E. coli by traditional heat shock and by electroporation  
 Before electroporating Rm cells with pUC18, the integrity of the plasmid was 
assessed by transforming E. coli cells with pUC18 plasmid.  As shown in Figure 5, both 
heat shock and electroporation methods were successful in transforming cells.  The cells 
were grown in LB plates with ampicillin (100 µg/mL) and incubated at 37 °C overnight.  
Growth on these AMP+ plates demonstrates successful transformation with pUC18 
plasmids, which contain ampicillin resistant genes.  It is also evident that the growth of 
electroporated transformants was comparable to those of the heat shocked E. coli cells 
(Figure 5).   
 
(A)      (B)  
Figure 5. E. coli grown on AMP+ LB agar plates after heat shock and 
electroporation with pUC18.  20 µL aliquots of E. coli cells were plated on each LB 
plate with 100 µg/mL of ampicillin after (A) heat shock and (B) electroporation. 
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 Next, to obtain sufficient pUC18 plasmid DNA for transformation of Rm cells, 
the pUC18 plasmids transformants of E. coli cells grown in AMP+ LB broth were lysed 
and the plasmids were isolated using Axygen MiniPrep kit.  Then, the concentrations and 
the purity of the Miniprep DNA was determined spectrophotometrically  (NanoDrop 
2000c, Thermo Scientific).  Isolated pUC18 plasmid from heat shocked and 
electroporated cells had a nucleic acid concentration of 270.8 ng/ µL and 193.1 ng/ µL, 
respectively (Table 4).  The absorbance of the plasmids showed similar peaks at 260 nm 
with a similar purity ratio (260/280nm) of 1.8 (Table 4, Figure 6), indicating pUC18 
plasmids DNA was pure. Next, the plasmid was treated with ECORI restriction enzymes 
and then gel electrophoresis was performed.  The molecular weight of the so digested 
pUC18 plasmid is 2686 base pairs (bp) in length.  The pUC18 plasmid bands were 
compared to the GeneRuler 1kb DNA ladder (ThermoScientific #SM0313) and both were 
between 2500 bp and 3000 bp (Figure 7).  This plasmid preparation was used for Rm 
electroporation. 
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(A)  
(B)  
Figure 6. The absorbance of isolated pUC18 plasmid from E. coli transformed by 
heat shock and electroporation.  After transforming E. coli cells by heat shock (A) and 
electroporation (B), pUC18 plasmids were isolated and analyzed for concentration and 
purity using a NanoDrop spectrophotometer (NanoDrop 2000c, Thermo Scientific).     
 
Table 4. Nucleic acid Concentration of pUC18 plasmid. 
Methods Concentration 
(ng/µL) 
A260/A280 
Heat shock 270.8 1.81 
Electroporation 193.1 1.80 
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Figure 7. Gel electrophoresis of pUC18 isolated from E. coli cells transformed by 
heat shock and electroporation.  After heat shock (left) and electroporation (right) the 
cells were treated with EcoRI restriction enzymes and ran the gel with 3µL of sample and 
4µL of ladder.  
3.5 Electroporation of Rm 
 After establishing the purity of pUC18 plasmids and discovering that the plasmids 
are capable of transforming E. coli, we then used pUC18 plasmids to electroporate Rm 
cells.  First, Rm cells were electroporated using the standard protocol for gram-positive 
bacteria with the field strength of 9kV* cm-1 (Table 5; Condition #1). It was found that 
such transformed Rm cells did not grow on the AMP+ plate, but did grow on the AMP- 
plate (Figure 8).  This meant that the cells were viable.  Next, various voltages were 
changed to attempt to optimize electroporation (Table 5).  However after increasing field 
strengths for electroporation of Rm cells (#2-5 from Table 5), there was no observable 
growth on any of the AMP+ or AMP- plates (Figure 9). No growth on the AMP- plates 
indicated that the cells had not survived the electroporation treatment.  
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Table 5.  Various conditions for electroporation of Rm cells. 
 Voltage 
(kV) 
Cuvette 
(cm) 
Field Strength 
(kV*cm-1) 
Time 
(msec) 
#1 1.8 0.2 9 2.5 
#2 1.8 0.1 18 2.5 
#3 1.8 0.1 18 4 
#4 2.1 0.1 21 1.1 
#5 2.1 0.1 21 2.5 
 
(A)        (B)  
Figure 8. Growth of Rm cells electroporated under the condition #1 on AMP- and 
AMP+ trypticase soy agar plate.  20µL of electroporated Rm cells were plated on 
trypticase soy agar plates with (A) AMP- and (B) AMP+ incubated at 37°C.  
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(A)       (B).  
Figure 9.  Growth of Rm cells electroporated under the condition #2 on AMP- and 
AMP+ trypticase soy agar plate.  20µL of electroporated Rm cells were plated on 
trypticase soy agar plates with  (A) AMP-  and (B) AMP+ incubated at 37°C.  
**Plates of conditions #3-5 are not shown.  
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4. Discussion 
  As the first step to investigate the presence of endogenous restriction enzymes in 
Rothia mucilaginosa (Rm) cells, the growth curve of Rm bacteria needed to be 
established.  The growth curve provided important information regarding the time course 
of Rm bacterial growth. The growth of Rm cells was monitored by measuring OD620, 
using a spectrophotometer, at indicated time points.  The data illustrated that there is a 
narrow window of time, between 7 to 10 hours of incubation with OD620 values between 
2.8 and 3.6 (Table 1), in which Rm cells are in the late logarithmic phase (Figure 2).  
 Second, it was important to prepare Rm cell lysate for determining endogenous 
restriction enzyme activities, which could jeopardize the subsequent transformation 
efforts.  The cells were sonicated to disrupt the cell membrane and release its cellular 
components including DNA.  Sonication uses sound waves to disrupt bacteria by 
exposure to high-frequency sound waves.  Using high power ultrasound (lower 
frequencies) in low volumes of bacterial suspension results in a continuous reduction in 
bacterial cell numbers (Joyce et al., 2003).  Compared to other techniques in isolating cell 
contents such as steam distillation, ultrasonication results in cleaner extractions, despite 
low recoveries (Linares P. et al., 1988).  In this study, sonication of Rm cells was 
successfully achieved because about 65%-75% of the cells could be lysed after 3 cycles 
(Figure 3 and Table 2).  The cells were placed on ice during sonication.  This is because 
of the rise in temperature due to acoustic cavitation, which is the formation, growth and 
collapse of small gas bubbles in liquids.  The uncontrolled rise in temperature due to 
cavitation can cause major problems including enzyme denaturation, which would result 
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in a false-negative result in the restriction enzyme activity assays.  
Restriction enzymes are consistently used for DNA modification and 
manipulation because of their ability to cleave DNA at specific sequences known as 
restriction or recognition sites (Xu, W. and Muller, S., 2011).  However in many of the 
cells, restriction enzymes are present as a way to protect the organism from 
contamination of unwanted DNA.  Importantly, this same “protective mechanism” may 
pose a challenge if cells are to be successfully transformed with foreign DNA.  Rm cells 
collected at late logarithmic stage were immersed in 4 different restriction enzyme 
buffers (1.1, 2.1, 3.1, and 4.1) before being sonicated.  
It was important to investigate the presence of restriction enzymes in a variety of 
buffers because different restriction enzymes have differing activities depending on the 
buffer types (Table 3). Buffer composition has a critical role on protein/protein or 
DNA/protein complex formation and stability, which can influence activities of 
restriction enzymes (Roder and Schweizer 2001).  Therefore, various buffers were 
utilized to detect the activities of as many restriction enzymes as possible.  Table 3 
illustrates only a fraction of restriction enzymes that are active depending on the buffer 
types, but there are over 200 enzymes that are characterized by performance in various 
buffers (www.neb.com).  However, our studies show not much evidence for the presence 
of pronounced restriction enzyme activities in the cell sonicate of Rm cells, in either of 
the restriction enzyme buffers evaluated. Thus, downstream complications with the 
degradation of plasmids or other DNA transformed into Rm were not indicated based on 
this result. 
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Lastly, we made a first attempt to electroporate with pUC18 plasmid. This 
plasmid contains ampicillin resistance gene and successful transformation could be 
investigated on agar supplemented with ampicillin antibiotic.  Before beginning to 
electroporate Rm cells, we transformed this plasmid into E. coli, by heat shock and 
electroporation.  E. coli, a gram-negative bacterium, was used because it easily undergoes 
transformation, unlike gram-positive bacteria that are notorious for resisting 
transformation.  As expected, pUC18 plasmid was successfully inserted into E. coli cells 
through heat shock and electroporation.  To confirm that pUC18 was the inserted 
plasmid, we purified the plasmid from the E. coli cells and obtained the purity ratio 
(A260/280) of about 1.8 (Table 4).  Generally, highly purified plasmid will exhibit an 
A260/280 = 1.7-1.9 demonstrating that the plasmid isolated was pure.  
Next, the validated pUC18 plasmid was electroporated into Rm cells with a field 
strength of 9kV*cm-1 using a standard protocol for gram-positive bacteria (#1 on Table 
5).  We found that Rm cells did not grow in the presence of ampicillin, indicating that 
transformation had not occurred.  Rm cells did grow on the agar plate without the 
presence of ampicillin, indicating the cells were alive and had survived the 
electroporation procedure.  In order to optimize the conditions to electroporate Rm cells, 
various conditions were used to electroporate Rm cells (Table 5).  These conditions were 
chosen because previous studies have demonstrated successful electroporation-mediated 
transformation of gram-positive bacteria using higher field strengths (Lofblom and 
Kronqvist et al., 2006; Metzler and Zhang et al., 1992).   
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Using the high voltage setting, however, Rm cells still did not grow in any of the 
plates that contained ampicillin.  Interestingly, Rm cells also did not grow on any of the 
AMP- plates either, which may suggest that the cells may have been killed due to high 
voltage usage.    
Future studies should be aware of this limitation that at a field strength that is 
higher than 18 kV*cm-1 may be detrimental to Rm cells eventually leading to cell death.  
Another limitation of this study is the compatibility of pUC18 plasmid with Rm cells.  
Although there is evidence of transforming gram-positive bacteria with the use of gram-
negative bacteria’s plasmid (Metzler et al., 1992), the transformation in our study to test 
for the validity of the plasmid was performed in E. coli, which is a gram-negative 
bacterium that are quite different from Rm cells.  It is possible that pUC18 plasmids may 
not be compatible with Rm cells for reasons that are unknown. If however, this plasmid is 
suitable, it is likely that there will be an optimum voltage setting whereby cell 
transformation of Rm can be achieved with minimal or no cell killing.    
 Despite the inability to successfully transform Rm cells by the varying voltage 
applied, this study uncovered many important aspects of Rm cells.  First, the growth 
curve of Rm bacteria has been established to facilitate future studies that require one to 
obtain cells at a specific stage of growth for manipulation.  Second, sonications of the Rm 
cells with 65%-75% cell lysis were achieved, and it has been established that endogenous 
restriction enzyme activities in this microorganisms are negligible.  Finally when 
electroporating Rm cells, the importance of varying field strengths greater than 9 kV*cm-
1 can potentially be deleterious to the cells.  
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In this study, various aspects of Rm bacteria was studied in an effort to create 
genetic knockout mutants for gluten-degrading enzyme activity.  Rm bacteria may play a 
crucial role in the detoxification and digestion of dietary gluten that can potentially 
benefit patients with celiac disease.  The usefulness of this bacterium as a novel 
therapeutic agent has yet to be determined, but this study has discovered many important 
characteristics of Rm.  The results from this study will aid future experiments to further 
optimize conditions to electroporate and facilitate genetic manipulation of this 
microorganism. 
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